Evaluation of the EC Action Plan Against the Rising Threats from Antimicrobial Resistance

Final Report - Appendices

Published in: Evaluation of the EC Action Plan Against the Rising Threats From Antimicrobial Resistance: Final Report - Appendices / Elta Smith, et al. (Luxembourg: Publications Office of the European Union, 2016), 648 p

Posted on RAND.org on November 03, 2016

by Elta Smith, Catherine A. Lichten, Jirka Taylor, Calum MacLure, Louise Lepetit, Emma Harte, Adam Martin, Ioana Ghiga, Emma Pitchforth, Jon Sussex, et al.

Read More

Access further information on this document at bookshop.europa.eu

This article was published outside of RAND. The full text of the article can be found at the link above.

Antimicrobial resistance (AMR) is a naturally occurring phenomenon where micro-organisms evolve abilities to survive drugs intended to kill them or stop their growth. The use of antimicrobials can speed up the emergence of AMR, and the challenges AMR brings are now compounded by an increase in resistance and a lack of new antimicrobial agents being developed. To tackle this issue, The European Commission developed the 'Action Plan against the Rising Threats from Antimicrobial Resistance', which covered the period 2011-2016 and aimed to address the problem of antimicrobial resistance (AMR) at the European level using a holistic approach. The Action Plan addressed the problem of AMR at European level across the following areas: monitoring and surveillance; appropriate use of antimicrobials; infection prevention; development of new antimicrobials, alternative treatments and diagnostic tools; improving understanding of AMR; and reinforcement and coordination of research efforts. The objectives also covered international cooperation and awareness, education and training. The evaluation objectives were to analyse whether the actions set out in the Action Plan were the most appropriate actions to be taken to combat AMR, and which elements worked well or not (and why). The objectives also included assessing whether the objectives were still relevant to the needs in tackling AMR and whether the approach was appropriately holistic. The set of appendices supplements the final report for the 'Evaluation of the EC Action Plan against the rising threats from antimicrobial resistance'.

Research conducted by

This report is part of the RAND Corporation External publication series. Many RAND studies are published in peer-reviewed scholarly journals, as chapters in commercial books, or as documents published by other organizations.

Our mission to help improve policy and decisionmaking through research and analysis is enabled through our core values of quality and objectivity and our unwavering commitment to the highest level of integrity and ethical behavior. To help ensure our research and analysis are rigorous, objective, and nonpartisan, we subject our research publications to a robust and exacting quality-assurance process; avoid both the appearance and reality of financial and other conflicts of interest through staff training, project screening, and a policy of mandatory disclosure; and pursue transparency in our research engagements through our commitment to the open publication of our research findings and recommendations, disclosure of the source of funding of published research, and policies to ensure intellectual independence. For more information, visit www.rand.org/about/principles.

The RAND Corporation is a nonprofit institution that helps improve policy and decisionmaking through research and analysis. RAND's publications do not necessarily reflect the opinions of its research clients and sponsors.